MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR-T cell therapy program for autoimmune diseases.

Treatments are the same as cancer sufferers but they don't receive the same support, a mother says.

LIG4 syndrome is an exceptionally rare disorder caused by a genetic mutation that prevents the body from repairing damaged ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...

such as in a French trial of gene therapy to correct X-linked severe combined immunodeficiency, where 25 percent of study participants developed leukemia from the therapy. Reaffirming the safety ...

A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its ...

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and fight cancer more effectively. They identified flaws in traditional methods, ...